Hubbry Logo
OsteoblastOsteoblastMain
Open search
Osteoblast
Community hub
Osteoblast
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Osteoblast
Osteoblast
Osteoblast
View on Wikipedia
from Wikipedia
Osteoblast
Osteoblasts (purple) rimming a bony spicule (pink - on diagonal of image). In this routinely fixed and decalcified (bone mineral removed) tissue, the osteoblasts have retracted and are separated from each other and from their underlying matrix. In living bone, the cells are linked by tight junctions and gap junctions, and integrated with underlying osteocytes and matrix H&E stain.
Illustration showing a single osteoblast
Details
LocationBone
FunctionFormation of bone tissue
Identifiers
Greekosteoblastus
MeSHD010006
THH2.00.03.7.00002
FMA66780
Anatomical terms of microanatomy

Osteoblasts (from the Greek combining forms for "bone", ὀστέο-, osteo- and βλαστάνω, blastanō "germinate") are cells with a single nucleus that synthesize bone. However, in the process of bone formation, osteoblasts function in groups of connected cells. Individual cells cannot make bone. A group of organized osteoblasts together with the bone made by a unit of cells is usually called the osteon.

Osteoblasts are specialized, terminally differentiated products of mesenchymal stem cells.[1] They synthesize dense, crosslinked collagen and specialized proteins in much smaller quantities, including osteocalcin and osteopontin, which compose the organic matrix of bone.

In organized groups of disconnected cells, osteoblasts produce hydroxyapatite, the bone mineral, that is deposited in a highly regulated manner, into the inorganic matrix forming a strong and dense mineralized tissue, the mineralized matrix. Hydroxyapatite-coated bone implants often perform better as those not coated with this material. For instance, in patients with fatty liver disease hydroxyapatite-coated titanium implants perform better as those not-coated with this material.[2] The mineralized skeleton is the main support for the bodies of air breathing vertebrates. It is also an important store of minerals for physiological homeostasis including both acid–base balance and calcium or phosphate maintenance.[3][4]

Bone structure

[edit]

The skeleton is a large organ that is formed and degraded throughout life in the air-breathing vertebrates. The skeleton, often referred to as the skeletal system, is important both as a supporting structure and for maintenance of calcium, phosphate, and acid–base status in the whole organism.[5] The functional part of bone, the bone matrix, is entirely extracellular. The bone matrix consists of protein and mineral. The protein forms the organic matrix. It is synthesized and then the mineral is added. The vast majority of the organic matrix is collagen, which provides tensile strength. The matrix is mineralized by deposition of hydroxyapatite (alternative name, hydroxylapatite). This mineral is hard, and provides compressive strength. Thus, the collagen and mineral together are a composite material with excellent tensile and compressive strength, which can bend under a strain and recover its shape without damage. This is called elastic deformation. Forces that exceed the capacity of bone to behave elastically may cause failure, typically bone fractures.[citation needed]

Bone remodeling

[edit]

Bone is a dynamic tissue that is constantly being reshaped by osteoblasts, which produce and secrete matrix proteins and transport mineral into the matrix, and osteoclasts, which break down the tissues.

Osteoblasts

[edit]

Osteoblasts are the major cellular component of bone. Osteoblasts arise from mesenchymal stem cells (MSC). MSC give rise to osteoblasts, adipocytes, and myocytes among other cell types. Osteoblast quantity is understood to be inversely proportional to that of marrow adipocytes which comprise marrow adipose tissue (MAT). Osteoblasts are found in large numbers in the periosteum, the thin connective tissue layer on the outside surface of bones, and in the endosteum.

Normally, almost all of the bone matrix, in the air breathing vertebrates, is mineralized by the osteoblasts. Before the organic matrix is mineralized, it is called the osteoid. Osteoblasts buried in the matrix are called osteocytes. During bone formation, the surface layer of osteoblasts consists of cuboidal cells, called active osteoblasts. When the bone-forming unit is not actively synthesizing bone, the surface osteoblasts are flattened and are called inactive osteoblasts. Osteocytes remain alive and are connected by cell processes to a surface layer of osteoblasts. Osteocytes have important functions in skeletal maintenance.

Osteoclasts

[edit]

Osteoclasts are multinucleated cells that derive from hematopoietic progenitors in the bone marrow which also give rise to monocytes in peripheral blood.[6] Osteoclasts break down bone tissue, and along with osteoblasts and osteocytes form the structural components of bone. In the hollow within bones are many other cell types of the bone marrow. Components that are essential for osteoblast bone formation include mesenchymal stem cells (osteoblast precursor) and blood vessels that supply oxygen and nutrients for bone formation. Bone is a highly vascular tissue, and active formation of blood vessel cells, also from mesenchymal stem cells, is essential to support the metabolic activity of bone. The balance of bone formation and bone resorption tends to be negative with age, particularly in post-menopausal women,[7] often leading to a loss of bone serious enough to cause fractures, which is called osteoporosis.

Osteogenesis

[edit]

Bone is formed by one of two processes: endochondral ossification or intramembranous ossification. Endochondral ossification is the process of forming bone from cartilage and this is the usual method. This form of bone development is the more complex form: it follows the formation of a first skeleton of cartilage made by chondrocytes, which is then removed and replaced by bone, made by osteoblasts. Intramembranous ossification is the direct ossification of mesenchyme as happens during the formation of the membrane bones of the skull and others.[8]

During osteoblast differentiation, the developing progenitor cells express the regulatory transcription factor Cbfa1/Runx2. A second required transcription factor is Sp7 transcription factor.[9] Osteochondroprogenitor cells differentiate under the influence of growth factors, although isolated mesenchymal stem cells in tissue culture may also form osteoblasts under permissive conditions that include vitamin C and substrates for alkaline phosphatase, a key enzyme that provides high concentrations of phosphate at the mineral deposition site.[1] In turn osteoblasts may give rise to osteocytes in a process dependent on the vascular musculature of blood vessels in the bone.[10]

Bone morphogenetic proteins

[edit]

Key growth factors in endochondral skeletal differentiation include bone morphogenetic proteins (BMPs) that determine to a major extent where chondrocyte differentiation occurs and where spaces are left between bones. The system of cartilage replacement by bone has a complex regulatory system. BMP2 also regulates early skeletal patterning. Transforming growth factor beta (TGF-β), is part of a superfamily of proteins that include BMPs, which possess common signaling elements in the TGF beta signaling pathway. TGF-β is particularly important in cartilage differentiation, which generally precedes bone formation for endochondral ossification. An additional family of essential regulatory factors is the fibroblast growth factors (FGFs) that determine where skeletal elements occur in relation to the skin

Steroid and protein hormones

[edit]

Many other regulatory systems are involved in the transition of cartilage to bone and in bone maintenance. A particularly important bone-targeted hormonal regulator is parathyroid hormone (PTH). Parathyroid hormone is a protein made by the parathyroid gland under the control of serum calcium activity.[4] PTH also has important systemic functions, including to keep serum calcium concentrations nearly constant regardless of calcium intake. Increasing dietary calcium results in minor increases in blood calcium. However, this is not a significant mechanism supporting osteoblast bone formation, except in the condition of low dietary calcium; further, abnormally high dietary calcium raises the risk of serious health consequences not directly related to bone mass including heart attack and stroke.[11] Intermittent PTH stimulation increases osteoblast activity, although PTH is bifunctional and mediates bone matrix degradation at higher concentrations.

The skeleton is also modified for reproduction and in response to nutritional and other hormone stresses; it responds to steroids, including estrogen and glucocorticoids, which are important in reproduction and energy metabolism regulation. Bone turnover involves major expenditures of energy for synthesis and degradation, involving many additional signals including pituitary hormones. Two of these are adrenocorticotropic hormone (ACTH)[12] and follicle stimulating hormone.[13] The physiological role for responses to these, and several other glycoprotein hormones, is not fully understood, although it is likely that ACTH is bifunctional, like PTH, supporting bone formation with periodic spikes of ACTH, but causing bone destruction in large concentrations. In mice, mutations that reduce the efficiency of ACTH-induced glucocorticoid production in the adrenals cause the skeleton to become dense (osteosclerotic bone).[14][15]

Organization and ultrastructure

[edit]

In well-preserved bone studied at high magnification via electron microscopy, individual osteoblasts are shown to be connected by tight junctions, which prevent extracellular fluid passage and thus create a bone compartment separate from the general extracellular fluid.[16] The osteoblasts are also connected by gap junctions, small pores that connect osteoblasts, allowing the cells in one cohort to function as a unit.[17] The gap junctions also connect deeper layers of cells to the surface layer (osteocytes when surrounded by bone). This was demonstrated directly by injecting low molecular weight fluorescent dyes into osteoblasts and showing that the dye diffused to surrounding and deeper cells in the bone-forming unit.[18] Bone is composed of many of these units, which are separated by impermeable zones with no cellular connections, called cement lines.

Collagen and accessory proteins

[edit]

Almost all of the organic (non-mineral) component of bone is dense collagen type I,[19] which forms dense crosslinked ropes that give bone its tensile strength. By mechanisms still unclear, osteoblasts secrete layers of oriented collagen, with the layers parallel to the long axis of the bone alternating with layers at right angles to the long axis of the bone every few micrometers. Defects in collagen type I cause the commonest inherited disorder of bone, called osteogenesis imperfecta.[20]

Minor, but important, amounts of small proteins, including osteocalcin and osteopontin, are secreted in bone's organic matrix.[21] Osteocalcin is not expressed at significant concentrations except in bone, and thus osteocalcin is a specific marker for bone matrix synthesis.[22] These proteins link organic and mineral component of bone matrix.[23] The proteins are necessary for maximal matrix strength due to their intermediate localization between mineral and collagen.

However, in mice where expression of osteocalcin or osteopontin was eliminated by targeted disruption of the respective genes (knockout mice), accumulation of mineral was not notably affected, indicating that organization of matrix is not significantly related to mineral transport.[24][25]

Bone versus cartilage

[edit]

The primitive skeleton is cartilage, a solid avascular (without blood vessels) tissue in which individual cartilage-matrix secreting cells, or chondrocytes, occur. Chondrocytes do not have intercellular connections and are not coordinated in units. Cartilage is composed of a network of collagen type II held in tension by water-absorbing proteins, hydrophilic proteoglycans.[26] This is the adult skeleton in cartilaginous fishes such as sharks. It develops as the initial skeleton in more advanced classes of animals.

In air-breathing vertebrates, cartilage is replaced by cellular bone. A transitional tissue is mineralized cartilage. Cartilage mineralizes by massive expression of phosphate-producing enzymes, which cause high local concentrations of calcium and phosphate that precipitate.[26] This mineralized cartilage is not dense or strong. In the air breathing vertebrates it is used as a scaffold for formation of cellular bone made by osteoblasts, and then it is removed by osteoclasts, which specialize in degrading mineralized tissue.

Osteoblasts produce an advanced type of bone matrix consisting of dense, irregular crystals of hydroxyapatite, packed around the collagen ropes.[27] This is a strong composite material that allows the skeleton to be shaped mainly as hollow tubes. Reducing the long bones to tubes reduces weight while maintaining strength.

Mineralization of bone

[edit]

The mechanisms of mineralization are not fully understood. Fluorescent, low-molecular weight compounds such as tetracycline or calcein bind strongly to bone mineral, when administered for short periods. They then accumulate in narrow bands in the new bone.[28] These bands run across the contiguous group of bone-forming osteoblasts. They occur at a narrow (sub-micrometer) mineralization front. Most bone surfaces express no new bone formation, no tetracycline uptake and no mineral formation. This strongly suggests that facilitated or active transport, coordinated across the bone-forming group, is involved in bone formation, and that only cell-mediated mineral formation occurs. That is, dietary calcium does not create mineral by mass action.

The mechanism of mineral formation in bone is clearly distinct from the phylogenetically older process by which cartilage is mineralized: tetracycline does not label mineralized cartilage at narrow bands or in specific sites, but diffusely, in keeping with a passive mineralization mechanism.[27]

Osteoblasts separate bone from the extracellular fluid by tight junctions [16] by regulated transport. Unlike in cartilage, phosphate and calcium cannot move in or out by passive diffusion, because the tight osteoblast junctions isolate the bone formation space. Calcium is transported across osteoblasts by facilitated transport (that is, by passive transporters, which do not pump calcium against a gradient).[27] In contrast, phosphate is actively produced by a combination of secretion of phosphate-containing compounds, including ATP, and by phosphatases that cleave phosphate to create a high phosphate concentration at the mineralization front. Alkaline phosphatase is a membrane-anchored protein that is a characteristic marker expressed in large amounts at the apical (secretory) face of active osteoblasts.

Major features of the bone-forming complex, the osteon, composed of osteoblasts and osteocytes.

At least one more regulated transport process is involved. The stoichiometry of bone mineral basically is that of hydroxyapatite precipitating from phosphate, calcium, and water at a slightly alkaline pH:[29]

6 HPO2−4 + 2 H2O + 10 Ca2+ ⇌ Ca10(PO4)6(OH)2 + 8 H+

In a closed system as mineral precipitates, acid accumulates, rapidly lowering the pH and stopping further precipitation. Cartilage presents no barrier to diffusion and acid therefore diffuses away, allowing precipitation to continue. In the osteon, where matrix is separated from extracellular fluid by tight junctions, this cannot occur. In the controlled, sealed compartment, removing H+ drives precipitation under a wide variety of extracellular conditions, as long as calcium and phosphate are available in the matrix compartment.[30] The mechanism by which acid transits the barrier layer remains uncertain. Osteoblasts have capacity for Na+/H+ exchange via the redundant Na/H exchangers, NHE1 and NHE6.[31] This H+ exchange is a major element in acid removal, although the mechanism by which H+ is transported from the matrix space into the barrier osteoblast is not known.

In bone removal, a reverse transport mechanism uses acid delivered to the mineralized matrix to drive hydroxyapatite into solution.[32]

Osteocyte feedback

[edit]

Feedback from physical activity maintains bone mass, while feedback from osteocytes limits the size of the bone-forming unit.[33][34][35] An important additional mechanism is secretion by osteocytes, buried in the matrix, of sclerostin, a protein that inhibits a pathway that maintains osteoblast activity. Thus, when the osteon reaches a limiting size, it deactivates bone synthesis.[36]

Morphology and histological staining

[edit]

Hematoxylin and eosin staining (H&E) shows that the cytoplasm of active osteoblasts is slightly basophilic due to the substantial presence of rough endoplasmic reticulum. The active osteoblast produces substantial collagen type I. About 10% of the bone matrix is collagen with the balance mineral.[29] The osteoblast's nucleus is spherical and large. An active osteoblast is characterized morphologically by a prominent Golgi apparatus that appears histologically as a clear zone adjacent to the nucleus. The products of the cell are mostly for transport into the osteoid, the non-mineralized matrix. Active osteoblasts can be labeled by antibodies to Type-I collagen, or using naphthol phosphate and the diazonium dye fast blue to demonstrate alkaline phosphatase enzyme activity directly.

  • Osteoblast (Wright Giemsa stain, 100x)
    Osteoblast (Wright Giemsa stain, 100x)
  • Light micrograph of decalcified cancellous bone displaying osteoblasts actively synthesizing osteoid, containing two osteocytes
    Light micrograph of decalcified cancellous bone displaying osteoblasts actively synthesizing osteoid, containing two osteocytes
  • Light micrograph of undecalcified tissue displaying osteoblasts actively synthesizing osteoid (center)
    Light micrograph of undecalcified tissue displaying osteoblasts actively synthesizing osteoid (center)
  • Light micrograph of undecalcified tissue displaying osteoblasts actively synthesizing rudimentary bone tissue (center)
    Light micrograph of undecalcified tissue displaying osteoblasts actively synthesizing rudimentary bone tissue (center)
  • Osteoblasts lining bone (H&E stain)
    Osteoblasts lining bone (H&E stain)

Isolation of Osteoblasts

[edit]
  1. The first isolation technique by microdissection method was originally described by Fell et al.[37] using chick limb bones which were separated into periosteum and remaining parts. She obtained cells which possessed osteogenic characteristics from cultured tissue using chick limb bones which were separated into periosteum and remaining parts. She obtained cells which possessed osteogenic characteristics from cultured tissue.
  2. Enzymatic digestion is one of the most advanced techniques for isolating bone cell populations and obtaining osteoblasts. Peck et al. (1964)[38] described the original method that is now often used by many researchers.
  3. In 1974 Jones et al.[39] found that osteoblasts moved laterally in vivo and in vitro under different experimental conditions and described the migration method in detail. The osteoblasts were, however, contaminated by cells migrating from the vascular openings, which might include endothelial cells and fibroblasts.

See also

[edit]

References

[edit]

Further reading

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Osteoblast

View on Grokipedia
from Grokipedia
Osteoblasts are specialized, cuboidal cells derived from mesenchymal stem cells that synthesize and mineralize the organic matrix, known as , to form the structural framework of tissue during development, growth, and repair. These cells constitute approximately 4-6% of all cells and are primarily located on the endosteal and periosteal surfaces of , where they actively contribute to osteogenesis through the secretion of components, including , , and . By facilitating the deposition of crystals, osteoblasts ensure the mineralization process that imparts rigidity and strength to the . The differentiation of osteoblasts begins with mesenchymal stromal cells (MSCs) committing to the osteoblastic lineage under the influence of key transcription factors such as Runx2 and Osterix, often triggered by signaling pathways like BMP and Wnt. This process involves distinct stages: proliferation of pre-osteoblasts, maturation with increased matrix protein production, and eventual function in bone formation. Osteoblasts exhibit a polygonal or cuboidal morphology, featuring abundant rough endoplasmic reticulum, Golgi apparatus, and mitochondria, which support their high secretory activity. In bone remodeling, osteoblasts work in close coordination with osteoclasts—the bone-resorbing cells—to maintain skeletal , adapting to mechanical stress and repairing microdamage. They regulate osteoclastogenesis by secreting factors such as (receptor activator of nuclear factor kappa-B ligand) and (OPG), which modulate the balance between bone formation and resorption. Additionally, mature osteoblasts may flatten into bone-lining cells that cover inactive bone surfaces or become embedded within the matrix to differentiate into osteocytes, which further influence bone maintenance through mechanosensory functions. Beyond structural roles, osteoblasts contribute to systemic by regulating calcium and levels and even endocrine functions, such as secreting to influence energy metabolism.

Biological Context

Bone Tissue Structure

Bone tissue displays a that enables it to fulfill its structural and physiological roles effectively. It is broadly classified into two main types: cortical (compact) bone and trabecular (spongy) bone. Cortical bone forms the dense outer shell of bones, accounting for about 80% of the skeletal mass, and is characterized by its low porosity (5-10%) and high compressive strength. This type is organized into structural units called osteons (or Haversian systems), which consist of concentric layers of mineralized matrix known as lamellae arranged around a central containing blood vessels, nerves, and lymphatics; these canals are interconnected by perpendicular . In contrast, trabecular bone constitutes the porous interior latticework, with porosity ranging from 50-90%, and is composed of interconnected struts or plates called trabeculae that align along lines of mechanical stress to optimize load distribution while minimizing weight. This spongy architecture is prevalent in regions like the epiphyses of long bones, vertebrae, and the pelvis, facilitating nutrient diffusion and metabolic exchange. Unlike the cylindrical osteons of cortical bone, trabecular bone lacks distinct Haversian systems but shares the same fundamental matrix components. Chemically, bone is a composite consisting of approximately 65-70% inorganic minerals by dry weight, primarily crystals with the formula \ceCa10(PO4)6(OH)2\ce{Ca10(PO4)6(OH)2}, which provide rigidity and resistance to compression; 25-30% organic matrix, predominantly fibers that confer tensile strength and flexibility; and 5-10% water, which aids in hydration and transport. The mineral phase imparts hardness, while the collagenous organic component allows for some deformation without fracture, creating a balance essential for withstanding diverse mechanical loads. As a dynamic , bone provides mechanical support and for vital organs, maintains mineral homeostasis by serving as a reservoir for , and other ions to regulate levels, and supports hematopoiesis through its marrow cavities where cells are produced. These multifaceted roles underscore bone's integration into broader physiological systems, adapting to stresses via ongoing structural adjustments. Histologically, bone tissue is distinguished by its matrix phases: osteoid, the unmineralized organic precursor rich in and , and the calcified matrix, where crystals are deposited within the osteoid to form the hardened proper. Osteoblasts produce the osteoid, which typically mineralizes within 10-15 days under normal conditions. This distinction highlights the transitional nature of bone formation, from soft extracellular material to rigid tissue.

Bone Remodeling Dynamics

Bone remodeling is a continuous, lifelong process that maintains skeletal integrity by replacing old or damaged with new tissue, ensuring mechanical strength and calcium . This dynamic cycle involves coordinated cellular activities across multiple cell types, preventing net bone loss under normal conditions. In adults, approximately 10% of the is remodeled annually, reflecting a balance between resorption and formation that adapts to physiological demands. The remodeling process unfolds in distinct phases within localized sites: , where signals initiate the cycle on quiescent surfaces; resorption, dominated by osteoclasts that excavate tissue; reversal, a transitional period preparing the site for rebuilding; formation, where new is laid down; and quiescence, marking the return to a resting state until the next cycle. These phases ensure sequential and efficient turnover, with the entire process typically lasting about 4 months in cortical and 6-7 months in trabecular . Central to this process is the coupling of to formation, which synchronizes osteoclast-mediated breakdown with subsequent rebuilding to preserve bone mass and architecture. This linkage occurs within basic multicellular units (BMUs), temporary teams of cells that operate in tunnels (in cortical bone) or trenches (on trabecular surfaces), advancing spatially and temporally to complete the cycle without disrupting overall structure. During the formation phase, osteoblasts contribute to matrix deposition, linking back to their role in synthesis as detailed in functional mechanisms. The rate and extent of remodeling are modulated by mechanical loading, which stimulates adaptation according to , and systemic factors that fine-tune turnover to meet calcium needs and repair microdamage. Increased loading enhances formation to reinforce stressed areas, while disuse accelerates resorption, highlighting the skeleton's responsiveness to physical and physiological cues.

Cellular Origin and Development

Mesenchymal Progenitor Origin

Osteoblasts primarily derive from mesenchymal stem cells (MSCs) residing in the bone marrow stroma, where these multipotent progenitors contribute to ongoing bone maintenance and repair. These stromal MSCs, often identified as a heterogeneous population including CXCL12+ and leptin receptor-positive cells, serve as a key reservoir for osteoblast replenishment during adult bone remodeling. Additionally, MSCs in the periosteum, the outer fibrous layer of bone, provide progenitors that support fracture healing and cortical bone formation, originating from the embryonic perichondrium. During embryonic development, osteoblast progenitors exhibit distinct origins depending on skeletal location. In the craniofacial skeleton, such as the facial bones and parts of the calvaria, progenitors arise from neural crest cells, which migrate from the neural tube and undergo mesenchymal transition to form osteogenic tissues. In contrast, the axial and appendicular skeleton derives progenitors from the paraxial mesoderm for the vertebral column and cranial vault, and from the lateral plate mesoderm for the limbs, highlighting the mesoderm's role in forming the majority of the body's bone framework. Progenitor MSCs for osteoblasts are characterized by specific cell surface markers that facilitate their identification and isolation. These include Stro-1, a marker enriched in the osteogenic subset of bone marrow MSCs, often co-expressed with CD146 to denote multipotent stromal cells capable of osteoblast lineage commitment. Additionally, CD105 () and CD73 (ecto-5'-nucleotidase) are universally recognized positive markers for MSCs, promoting and signaling essential for their osteogenic potential, as defined by international consensus criteria. In bone formation, these mesenchymal progenitors play differential roles based on the ossification mode. During , which forms flat bones like those of the and , progenitors directly differentiate into osteoblasts without a cartilaginous intermediate, condensing mesenchymal tissue into ossification centers. Conversely, in for long bones and the , progenitors initially form a template via chondrogenic commitment, with subsequent vascular invasion enabling osteoblast recruitment from surrounding perichondrial and marrow sources to replace the scaffold.

Differentiation Pathways

Osteoblast differentiation proceeds through a series of sequential stages beginning with mesenchymal progenitors, which commit to the osteoblast lineage and mature progressively into functional -forming cells and eventually osteocytes. The process initiates with mesenchymal stem cells (MSCs) differentiating into pre-osteoblasts, characterized by proliferation and expression of early lineage markers. These pre-osteoblasts then advance to immature osteoblasts, where they deposit components, followed by maturation into fully functional osteoblasts capable of mineralization. Finally, a subset of mature osteoblasts embed within the matrix and terminally differentiate into osteocytes, which maintain integrity through mechanosensory functions. Central to this differentiation cascade are the master transcription factors and Osterix (Osx, also known as Sp7), which drive commitment and maturation in a sequential manner. is activated early in pre-osteoblasts, initiating the osteoblast program by upregulating genes for proliferation and early matrix proteins while suppressing alternative lineages; its expression peaks during the immature stage before declining in mature cells. Osterix acts downstream of , becoming prominently expressed in immature and mature osteoblasts to promote terminal differentiation, matrix maturation, and mineralization; without Osx, -expressing cells fail to progress beyond the pre-osteoblast stage. This hierarchical regulation ensures precise control, with enabling initial commitment and Osx facilitating advanced functionality. Lineage commitment to osteoblasts involves active inhibition of adipogenic and chondrogenic pathways, primarily through Wnt/β-catenin signaling, which favors osteogenic over alternative fates. Activation of canonical Wnt/β-catenin in mesenchymal progenitors stabilizes β-catenin, enhancing expression and repressing adipogenic transcription factors like PPARγ, thereby preventing fat cell differentiation. Similarly, it inhibits chondrogenic commitment by downregulating , directing progenitors away from formation and toward . This signaling pathway establishes a bias toward osteoblastogenesis, ensuring multipotent MSCs adopt the appropriate skeletal lineage. In vitro models of osteoblast differentiation commonly employ chemical inducers to recapitulate these stages using MSC cultures. Supplementation with ascorbic acid promotes synthesis and matrix deposition, essential for the immature osteoblast phase, while β-glycerophosphate provides a source to drive mineralization in mature cells. These agents, often combined in osteogenic media, induce robust differentiation, as evidenced by increased activity and calcium nodule formation, mimicking progression without relying on complex tissue environments.

Structural Features

Cellular Organization

Osteoblasts are primarily located along the surfaces of tissue, serving as the key cellular components responsible for formation and maintenance. They populate the , the thin layer of lining the of long bones, and the , which covers the outer surface of bones. In these regions, osteoblasts exist in two main morphological states: active cuboidal cells at sites of ongoing formation, where they actively synthesize matrix, and flattened resting cells known as bone lining cells that cover quiescent surfaces, such as areas not undergoing resorption or formation. During active bone formation, osteoblasts align in organized layers to facilitate coordinated matrix deposition. These cells typically form a monolayer of cuboidal osteoblasts on the surface of newly forming bone, which contributes to the structured layering observed in osteons, the cylindrical units of compact bone. Within osteons, osteoblasts deposit matrix in concentric lamellae, with each lamella consisting of aligned collagen fibers and minerals, typically 2-µm thick, allowing for the progressive building of bone tissue around a central vascular canal. This layered alignment ensures efficient and directional bone growth, with 4–8 lamellae commonly present in mature secondary osteons. Osteoblasts exhibit distinct cellular polarity that supports their secretory function. The basolateral surface of these cells faces the vasculature, enabling uptake and , while the apical surface orients toward the matrix, directing the secretion of , the unmineralized precursor to . This polarization maintains a barrier-like organization, with osteoblasts forming tight epithelial-like layers that isolate the matrix from surrounding marrow spaces. In active formation sites, osteoblasts comprise approximately 4–6% of all cells, reflecting their localized but critical role in tissue architecture.

Ultrastructure and Organelles

Osteoblasts display a distinctive adapted for their role in intensive protein synthesis and during bone formation. The is rich in organelles specialized for biosynthetic processes, including an extensive network of rough endoplasmic reticulum (rER) and a well-developed Golgi apparatus. These features reflect the cell's high demand for producing and modifying large quantities of extracellular proteins. reveals that active osteoblasts maintain a polarized morphology, with their secretory apparatus oriented toward the surface. The rough endoplasmic reticulum is particularly prominent in mature osteoblasts, forming extensive cisternae that facilitate the and folding of secretory proteins such as . This abundance of rER underscores the cell's synthetic capacity, as ribosomes stud the membranes to support the ongoing production of bone matrix components. Adjacent to the rER, the Golgi apparatus is enlarged and consists of stacked cisternae and numerous vesicles, enabling the , sorting, and packaging of proteins for . These organelles work in concert to ensure efficient transit of molecules from synthesis to , a process critical for deposition. Mitochondria are abundant throughout the osteoblast cytoplasm, providing the ATP necessary for the energy-intensive processes of protein synthesis, vesicle transport, and mineralization initiation. These organelles exhibit cristae-rich matrices optimized for , maintaining high bioenergetic output during peak activity phases. , a key for provision in formation, is primarily localized to the plasma membrane, often anchored via linkages on the cell surface facing the matrix. This strategic positioning allows rapid of substrates to support local mineralization. The in osteoblasts comprises filaments and that maintain structural integrity and facilitate intracellular dynamics. filaments form a cortical network that helps preserve the cuboidal shape of active osteoblasts and supports membrane stability during secretion. , radiating from the , serve as tracks for motor proteins like and , enabling directed vesicle transport from the Golgi to the plasma membrane. This cytoskeletal organization ensures precise delivery of secretory cargoes, enhancing the efficiency of matrix elaboration. Intercellular communication is mediated by gap junctions composed primarily of connexin 43 (Cx43), which form hexameric channels between adjacent osteoblasts. These structures allow the passage of small molecules such as ions, , and second messengers, coordinating synchronized activity across cell layers during bone formation. Cx43 gap junctions are particularly dense in osteoblast populations, promoting metabolic coupling and signal propagation essential for tissue-level responses.

Functional Mechanisms

Extracellular Matrix Synthesis

Osteoblasts are the primary cells responsible for synthesizing the organic (ECM) of , which serves as the scaffold for subsequent tissue mineralization. This matrix is predominantly composed of proteins secreted by osteoblasts into the , where they assemble into a structured network that provides mechanical support and facilitates cellular interactions. The synthesis process involves coordinated intracellular production, , and extracellular assembly, ensuring the formation of a robust and organized matrix essential for integrity. Type I collagen constitutes approximately 90% of the protein content in the ECM and is the dominant structural component produced by osteoblasts. Within the osteoblast, two procollagen chains (α1 and α2) undergo posttranslational modifications, including and , before forming a structure. This procollagen is then secreted into the , where N- and C-terminal propeptides are cleaved by procollagen peptidases, yielding mature tropocollagen molecules. These tropocollagen units spontaneously self-assemble in a staggered array to form , which further aggregate into larger fibers. To enhance the stability and tensile strength of these , osteoblasts promote cross-linking through the lysyl oxidase, which oxidizes specific and hydroxylysine residues to form covalent bonds between molecules. This enzymatic process, occurring extracellularly, is crucial for the maturation and insolubility of the network, preventing premature degradation and contributing to the overall durability of the bone matrix. In addition to , osteoblasts secrete various non-collagenous proteins that comprise about 5-10% of the ECM and play key roles in modulating and matrix regulation. , a vitamin K-dependent protein, aids in regulating osteoblast function and matrix organization through its interactions with other ECM components. facilitates osteoblast adhesion to the matrix via binding and helps regulate cellular responses during matrix deposition. Bone sialoprotein similarly promotes osteoblast attachment and spreading through RGD-mediated interactions with , while also influencing matrix assembly and cellular signaling. Accessory proteins such as s further contribute to ECM organization. For instance, , a small leucine-rich secreted by osteoblasts, binds to to regulate their lateral assembly and spacing, thereby controlling fibril diameter and overall matrix architecture. This interaction ensures proper alignment and prevents excessive bundling, supporting the biomechanical properties of the bone ECM.

Mineralization Processes

Osteoblasts initiate bone mineralization through the secretion of matrix vesicles, which serve as the primary sites for nucleation. These extracellular vesicles, derived from the osteoblast plasma membrane, contain high concentrations of (ALP), an enzyme that hydrolyzes inorganic —a potent inhibitor of mineralization—into inorganic . This elevates local phosphate levels, facilitating the influx of calcium ions and promoting the initial formation of crystals within the vesicle interior. Crystal growth proceeds extracellularly once the initial seeds propagate beyond the matrix vesicles. Calcium and ions, sourced from the bloodstream and local , supersaturate the environment around the vesicles, leading to the deposition of with the \ceCa10(PO4)6(OH)2\ce{Ca10(PO4)6(OH)2}. fibrils, previously assembled by osteoblasts as a scaffold, act as heterogeneous templates, aligning the plate-like crystals parallel to the axis to enhance mechanical strength. This templated growth ensures ordered mineralization, transforming the organic matrix into a composite . The mineralization process unfolds in two distinct phases: primary and secondary. Primary mineralization is rapid, occurring within hours to days after matrix deposition, and accounts for approximately 70% of the final mineral content through the initial nucleation and propagation facilitated by matrix vesicles. Secondary mineralization follows more slowly, over weeks to months, involving the gradual of ions into the deeper matrix layers and further maturation, which increases and . These phases are tightly controlled by osteoblasts to balance formation with structural integrity. Osteoblasts regulate mineralization through the expression of inhibitors and promoters to prevent pathological over- or under-mineralization. , a non-collagenous protein secreted by osteoblasts, binds to surfaces and inhibits excessive crystal growth, thereby limiting mineral over-deposition and maintaining matrix pliability. Similarly, (MGP), which undergoes vitamin K-dependent γ-carboxylation, modulates mineralization by regulating crystal propagation in the bone matrix, with its carboxylated form preventing uncontrolled while supporting ordered deposition. These regulatory proteins ensure precise control over the mineralization extent.

Regulatory Mechanisms

Hormonal and Growth Factor Control

Osteoblasts are primarily regulated by a suite of hormonal and signals that modulate their proliferation, differentiation, and synthetic activity through endocrine and paracrine mechanisms. These extrinsic factors integrate systemic cues to maintain , with anabolic effects promoting matrix deposition and mineralization, while catabolic influences suppress osteoblast function. Key regulators include (PTH), , bone morphogenetic proteins (BMPs), insulin-like growth factor-1 (IGF-1), , and glucocorticoids, each acting via distinct receptor-mediated pathways to fine-tune osteoblast responses. Parathyroid hormone (PTH) exerts dual effects on osteoblasts depending on the mode of administration. Intermittent PTH exposure, as seen in or therapeutic dosing, stimulates osteoblast proliferation, differentiation, and survival by activating the cAMP/ (PKA) pathway, leading to anabolic bone formation and increased bone mass. In contrast, continuous PTH elevation, characteristic of , inhibits osteoblast differentiation and promotes bone resorption indirectly by upregulating expression in osteoblasts, resulting in net bone loss despite initial stimulation of formation. These differential outcomes arise from distinct profiles induced by transient versus sustained cAMP signaling, with intermittent PTH also reducing sclerostin to enhance Wnt/β-catenin activity. The active form of vitamin D, 1,25-dihydroxyvitamin D3 (), promotes osteoblast maturation and function by binding to the (VDR) in osteoblasts, thereby upregulating genes essential for bone matrix synthesis. Notably, induces expression of , a marker of differentiated osteoblasts, and enhances activity to support mineralization. Additionally, maintains systemic calcium by directly enhancing intestinal calcium absorption and renal calcium . Locally, it drives the osteoblast-osteocyte transition via dentin matrix protein-1 and fibroblast growth factor-23 (FGF-23) expression. Among growth factors, bone morphogenetic protein-2 () is a potent inducer of osteoblast differentiation from mesenchymal progenitors, acting primarily through canonical Smad signaling. binds to type I and II serine/ receptors, phosphorylating receptor-regulated Smads (Smad1/5/8) that complex with Smad4 to translocate to the nucleus and activate transcription factors like and osterix (Osx), thereby promoting and expression. This pathway enhances production and mineralization, with non-canonical MAPK contributions amplifying the response in mature osteoblasts. Ins insulin-like growth factor-1 (IGF-1) supports osteoblast proliferation and survival, exerting paracrine effects within the microenvironment. IGF-1 binds to its , activating downstream PI3K/Akt and MAPK/ERK pathways to stimulate progression and inhibit , thereby increasing osteoblast numbers and bone formation rates. In osteoblasts, IGF-1 also couples formation to resorption by modulating /OPG expression, with local production by osteoblasts amplifying these effects during remodeling. Estrogen maintains osteoblast longevity by inhibiting , particularly through α (ERα)-mediated non-genomic signaling. 17β-estradiol activates Src/Shc/ERK pathways to suppress pro-apoptotic JNK signaling and promote , extending osteoblast lifespan and sustaining formation in estrogen-replete states. This anti-apoptotic action is critical for countering postmenopausal loss, as estrogen depletion elevates osteoblast rates. Glucocorticoids, such as , suppress osteoblast function and contribute to loss in excess. They bind glucocorticoid receptors in osteoblasts to inhibit proliferation and differentiation by downregulating and expression, while promoting through enhanced activity. This leads to reduced matrix synthesis and mineralization, with additional effects on increasing to favor resorption, underscoring glucocorticoids' catabolic dominance in osteoblast regulation.

Cellular Interactions and Feedback

Osteoblasts play a central role in by communicating with through the RANKL-OPG axis, which tightly couples bone formation and resorption. Osteoblasts express receptor activator of nuclear factor kappa-B ligand (), a membrane-bound or soluble that binds to on osteoclast precursors, thereby activating downstream signaling pathways essential for differentiation and activation. This interaction specifically triggers the pathway in osteoclast precursors, where RANKL binding recruits TRAF6 to activate IKKβ, leading to degradation and nuclear translocation of subunits (RelA/p50), which upregulate transcription factors like NFATc1 and c-Fos to promote osteoclastogenesis. In contrast, osteoblasts also secrete (OPG), a soluble decoy receptor that competitively binds RANKL, preventing its interaction with RANK and thereby inhibiting formation to maintain balanced remodeling. The ratio of RANKL to OPG expression by osteoblasts thus serves as a key regulatory mechanism for activity. Interactions between osteocytes and osteoblasts further fine-tune bone formation via signaling molecules that respond to mechanical cues. Osteocytes, terminally differentiated osteoblasts embedded in the matrix, sense mechanical strain through their extensive dendritic network and modulate osteoblast activity accordingly. Under mechanical loading, osteocytes downregulate sclerostin (SOST), a Wnt pathway inhibitor, thereby allowing Wnt/β-catenin signaling to activate osteoblast proliferation and differentiation on bone surfaces. Conversely, in response to unloading or low strain, osteocytes upregulate sclerostin secretion, which binds to /6 co-receptors on osteoblasts, suppressing Wnt signaling and inhibiting new bone formation to adapt to reduced mechanical demands. This sclerostin-mediated feedback loop ensures that osteoblast function aligns with the 's mechanical environment. Paracrine signaling via the ephrinB2-EphB4 axis provides bidirectional communication that couples and functions during remodeling. express the EphB4 receptor, while and their express the ephrinB2 ; forward signaling through EphB4 in promotes their differentiation and mineralizing activity, enhancing formation. Simultaneously, reverse signaling through ephrinB2 in inhibits c-Fos expression and osteoclastogenesis, thereby limiting to coordinate with -driven deposition. This reciprocal interaction helps synchronize the activities of these cell types, preventing uncoupled remodeling that could lead to loss or excess. The lifecycle of osteoblasts includes regulated and transition to osteocytes, which influences long-term maintenance. During matrix deposition, a subset of osteoblasts becomes embedded within the they produce, undergoing morphological changes to form osteocytes while extending cytoplasmic processes to form a lacunocanalicular network for nutrient exchange and signaling. Only approximately 10-20% of osteoblasts successfully embed and survive as osteocytes, with the majority undergoing to prevent overaccumulation and support tissue renewal. This low survival rate is regulated by factors such as TGF-β activation via matrix metalloproteinases, which promotes anti-apoptotic pathways like ERK1/2 during the process. Apoptotic osteoblasts release signals that can further modulate neighboring cell interactions, reinforcing feedback in .

Experimental and Clinical Aspects

Isolation and Cultivation Techniques

Primary osteoblasts are typically isolated from neonatal rodent calvaria or long bones through sequential enzymatic digestion to release cells embedded in the bone matrix. The process begins with euthanizing 2- to 5-day-old mice or rats, dissecting the calvaria or long bones under sterile conditions, and performing multiple digestion steps using collagenase (e.g., 1-3 mg/mL collagenase type II or A) in a buffer like Hank's balanced salt solution or Opti-MEM at 37°C with gentle agitation for 20-30 minutes per step, usually 4-5 cycles. The first one or two digests primarily release non-osteoblastic cells such as fibroblasts and hematopoietic cells, while subsequent digests (3-5) enrich for osteoblast precursors, yielding populations with high alkaline phosphatase activity for selection and confirmation of osteoblastic identity. Typical yields range from 4 × 10^6 to 5 × 10^6 cells per litter of 6-8 neonatal mice, though per bone yields are approximately 10^5 to 10^6 cells, depending on animal age and digestion efficiency. To complement primary cultures, immortalized cell lines serve as reliable models for osteoblast studies, offering consistent reproducibility and human-like characteristics. The MC3T3-E1 line, derived from newborn mouse calvaria, is a non-transformed clonal pre-osteoblast model that undergoes stepwise differentiation mimicking osteogenesis. Similarly, the SaOS-2 line, established from human , exhibits osteoblastic features such as mineralized matrix production under appropriate conditions, making it suitable for studying human-relevant pathways. Standard culture conditions for both primary and cell line osteoblasts involve basal media supplemented to support proliferation and differentiation. Primary cells and MC3T3-E1 are maintained in α-MEM or DMEM with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37°C in 5% CO₂, with plating densities of 10,000-12,000 cells/cm² and medium changes every 2-3 days. SaOS-2 cells are cultured in McCoy's 5A medium with 15% FBS under the same atmospheric conditions. For matrix production and mineralization, ascorbic acid (50 μg/mL) is added to induce collagen synthesis, often combined with β-glycerophosphate (10 mM) and dexamethasone (100 nM) in osteogenic media. To better replicate environments, osteoblasts are increasingly cultured on 3D scaffolds such as gels, hydroxyapatite-coated , or alginate hydrogels, which enhance cell-cell interactions and deposition compared to 2D monolayers. These scaffolds promote higher osteogenic differentiation, with seeding densities around 1.5 × 10^6 cells per scaffold and or static culture for 21 days to support long-term viability and mineralized nodule formation. Key challenges in osteoblast isolation and cultivation include avoiding by non-osteogenic cells like fibroblasts, which can be mitigated by differential adhesion and selective plating from later digests, and preserving the differentiation state, as over-confluence or prolonged passaging (beyond 3-4 passages for primaries) leads to phenotypic drift. Low initial yields from adult bones compared to neonatal sources further complicate scalability, necessitating optimized enzymatic conditions to maximize osteoblast-enriched fractions.

Pathology and Therapeutic Implications

Osteoblast dysfunction plays a central role in several bone pathologies, particularly those involving imbalanced mineralization and bone formation. In , especially the postmenopausal form, deficiency accelerates osteoblast , reducing bone formation and leading to net bone loss. This -mediated effect increases susceptibility to fragility fractures by impairing osteoblast survival and function. For instance, withdrawal of from osteoblasts and osteocytes directly promotes and excessive mineralization , contributing to the skeletal fragility observed in affected individuals. In contrast, and related disorders feature excessive bone density due to overactive mineralization, often stemming from impaired resorption that secondarily enhances relative osteoblast activity. Certain osteopetrosis-like conditions arise from osteoblast-specific genetic deficiencies, such as inhibition of receptor α signaling, which disrupt normal and lead to pathological hyper-mineralization and narrowed marrow cavities. These abnormalities highlight how dysregulated osteoblast function can contribute to sclerotic phenotypes in rare metabolic diseases. Osteoblasts are also implicated in oncological processes affecting . In , tumor cells promote osteoblastic metastases through secretion of endothelin-1 (ET-1), which stimulates osteoblast proliferation and new bone formation at metastatic sites. This ET-1-mediated results in mixed osteolytic and osteoblastic lesions, exacerbating skeletal complications in advanced disease. Similarly, frequently originates from mesenchymal stem cells or committed osteoblast precursors, where genetic alterations drive uncontrolled osteogenic differentiation and tumor formation. Evidence supports osteoblast lineage cells as a primary origin, with mutations in genes like RB1 reinforcing this tumorigenic pathway. Therapeutic strategies targeting osteoblast function have advanced the management of these conditions. Anabolic agents like teriparatide, a recombinant parathyroid hormone (PTH) analog, stimulate osteoblast activity when administered intermittently, increasing bone formation and reducing fracture risk in osteoporosis patients. This PTH-mediated enhancement promotes osteoblast proliferation and survival, leading to net gains in bone mass. Another key intervention is romosozumab, a monoclonal anti-sclerostin antibody that activates the Wnt/β-catenin pathway in osteoblasts, boosting bone formation while inhibiting resorption; clinical trials demonstrate its efficacy in rapidly increasing bone mineral density and preventing vertebral fractures. As of 2025, real-world studies confirm romosozumab's effectiveness, with 12-month treatment yielding approximately 14-15% increases in lumbar spine bone mineral density. Post-2020 research has introduced innovative approaches to harness osteoblast potential for regeneration. editing of the gene, a master regulator of osteoblast differentiation, has been explored to enhance osteogenic commitment in stem cells, offering promise for treating bone defects and through targeted genetic modulation. Additionally, osteoblast-targeted nanodelivery systems, such as peptide-functionalized nanoparticles delivering β-catenin agonists, accumulate at sites to stimulate osteoblast activity and accelerate ; these platforms improve and regenerative outcomes in of bone injury. Such advances underscore the shift toward precision therapies that directly augment osteoblast function in clinical settings.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK557792/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC4515490/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC5612831/
  4. https://www.nature.com/articles/s41413-018-0019-6
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC6958555/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC3152283/
  7. https://www.doitpoms.ac.uk/tlplib/bones/structure.php
  8. https://open.oregonstate.education/anatomy2e/chapter/bone-structure/
  9. https://www.sciencedirect.com/topics/veterinary-science-and-veterinary-medicine/bone-tissue
  10. https://www.orthobullets.com/basic-science/9001/types-of-bone
  11. https://www.osteoporosis.foundation/health-professionals/about-osteoporosis/bone-biology
  12. https://www.nature.com/articles/s41598-019-44620-6
  13. https://www.ncbi.nlm.nih.gov/books/NBK537199/
  14. https://pressbooks-dev.oer.hawaii.edu/anatomyandphysiology/chapter/the-functions-of-the-skeletal-system/
  15. https://www.nature.com/articles/s41413-021-00142-4
  16. https://www.sciencedirect.com/topics/immunology-and-microbiology/bone-matrix
  17. https://pmc.ncbi.nlm.nih.gov/articles/PMC10648520/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC2880220/
  19. https://www.sciencedirect.com/topics/immunology-and-microbiology/bone-remodeling
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC6734079/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC3899560/
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC3028072/
  23. https://www.ncbi.nlm.nih.gov/books/NBK499863/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC3743123/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC8338797/
  26. https://www.nature.com/articles/s12276-020-0482-1
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC7484058/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC3278574/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC3178966/
  30. https://www.ncbi.nlm.nih.gov/books/NBK10056/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC5040224/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC3725781/
  33. https://www.nature.com/articles/s41421-024-00689-6
  34. https://www.mdpi.com/1422-0067/20/7/1694
  35. https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2020.601224/full
  36. https://www.mdpi.com/2218-273X/15/7/1043
  37. https://www.pnas.org/doi/10.1073/pnas.1619294114
  38. https://www.researchgate.net/publication/40043113_Regulation_of_Osteoblast_Differentiation_by_Runx2
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC3854789/
  40. https://www.nature.com/articles/s41598-023-40835-w
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC6985832/
  42. https://www.sciencedirect.com/topics/materials-science/osteoblast
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC9063188/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC3566324/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC11371665/
  46. https://www.sciencedirect.com/science/article/pii/S8756328204003047
  47. https://pmc.ncbi.nlm.nih.gov/articles/PMC8217329/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC3367377/
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC7264100/
  50. https://www.ncbi.nlm.nih.gov/books/NBK507709/
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC1352157/
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC5382067/
  53. https://pmc.ncbi.nlm.nih.gov/articles/PMC6830090/
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC5426847/
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC3038101/
  56. https://www.sciencedirect.com/science/article/abs/pii/S8756328207004000
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC2650102/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC2435686/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC2783689/
  60. https://pubmed.ncbi.nlm.nih.gov/20154452/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC8615537/
  62. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508610/
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC8064082/
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC5467150/
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC4544393/
  66. https://pubmed.ncbi.nlm.nih.gov/36077336/
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC6280711/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC1850905/
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC6549463/
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC6059683/
  71. https://pmc.ncbi.nlm.nih.gov/articles/PMC5407089/
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC1995599/
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC3988399/
  74. https://pmc.ncbi.nlm.nih.gov/articles/PMC3405161/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC9919888/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC444857/
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC3269610/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC8237273/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC2726838/
  80. https://www.nature.com/articles/labinvest201463
  81. https://www.sciencedirect.com/science/article/pii/S0167488919301065
  82. https://www.sciencedirect.com/science/article/pii/S1550413110001580
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC9008133/
  84. https://pmc.ncbi.nlm.nih.gov/articles/PMC10608105/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC10613774/
  86. https://academic.oup.com/edrv/article/29/2/155/2354996
  87. https://pmc.ncbi.nlm.nih.gov/articles/PMC2349095/
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC5340132/
  89. https://aap.onlinelibrary.wiley.com/doi/10.1359/jbmr.090411
  90. https://www.jbc.org/article/S0021-9258%2820%2940232-7/fulltext
  91. https://www.sciencedirect.com/science/article/pii/S1550413106002038
  92. https://pubmed.ncbi.nlm.nih.gov/16890539/
  93. https://pmc.ncbi.nlm.nih.gov/articles/PMC3499314/
  94. https://anatomypubs.onlinelibrary.wiley.com/doi/10.1002/dvdy.20603
  95. https://journals.physiology.org/doi/full/10.1152/physrev.00043.2020
  96. https://www.sciencedirect.com/science/article/pii/S0021925819717530
  97. https://www.nature.com/articles/s41413-024-00341-9
  98. https://pubmed.ncbi.nlm.nih.gov/24482182/
  99. https://pubmed.ncbi.nlm.nih.gov/22130919/
  100. https://pubmed.ncbi.nlm.nih.gov/3040234/
  101. https://pubmed.ncbi.nlm.nih.gov/30369260/
  102. https://pubmed.ncbi.nlm.nih.gov/38393588/
  103. https://pubmed.ncbi.nlm.nih.gov/19426747/
  104. https://pubmed.ncbi.nlm.nih.gov/24446157/
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC11487257/
  106. https://pubmed.ncbi.nlm.nih.gov/12548575/
  107. https://pubmed.ncbi.nlm.nih.gov/12941866/
  108. https://pubmed.ncbi.nlm.nih.gov/24530473/
  109. https://pubmed.ncbi.nlm.nih.gov/26768289/
  110. https://pubmed.ncbi.nlm.nih.gov/38789679/
  111. https://pmc.ncbi.nlm.nih.gov/articles/PMC12072299/
  112. https://www.sciencedirect.com/science/article/pii/S2211124722011391
  113. https://josr-online.biomedcentral.com/articles/10.1186/s13018-024-05163-3
  114. https://pmc.ncbi.nlm.nih.gov/articles/PMC9554751/
  115. https://pmc.ncbi.nlm.nih.gov/articles/PMC5736386/
  116. https://pmc.ncbi.nlm.nih.gov/articles/PMC11100250/
Add your contribution
Related Hubs
User Avatar
No comments yet.